236 related articles for article (PubMed ID: 37105192)
1.
Chung CP; Karakoc G; Dickson A; Liu G; Gamboa JL; Mosley JD; Cox NJ; Kawai VK
Lupus; 2023 May; 32(6):763-770. PubMed ID: 37105192
[TBL] [Abstract][Full Text] [Related]
2. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.
Blazer A; Wang B; Simpson D; Kirchhoff T; Heffron S; Clancy RM; Heguy A; Ray K; Snuderl M; Buyon JP
PLoS One; 2017; 12(8):e0182483. PubMed ID: 28850570
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
Langefeld CD; Comeau ME; Ng MCY; Guan M; Dimitrov L; Mudgal P; Spainhour MH; Julian BA; Edberg JC; Croker JA; Divers J; Hicks PJ; Bowden DW; Chan GC; Ma L; Palmer ND; Kimberly RP; Freedman BI
Kidney Int; 2018 Sep; 94(3):599-607. PubMed ID: 29885931
[TBL] [Abstract][Full Text] [Related]
5. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
[TBL] [Abstract][Full Text] [Related]
6. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
[TBL] [Abstract][Full Text] [Related]
7. Association between
Jiang L; Liu G; Oeser A; Ihegword A; Dickson AL; Daniel LL; Hung AM; Cox NJ; Chung CP; Wei WQ; Stein CM; Feng Q
Elife; 2023 Oct; 12():. PubMed ID: 37882666
[TBL] [Abstract][Full Text] [Related]
8. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.
Gutiérrez OM; Irvin MR; Zakai NA; Naik RP; Chaudhary NS; Estrella MM; Limou S; Judd SE; Cushman M; Kopp JB; Winkler CA
Am J Kidney Dis; 2020 Jan; 75(1):54-60. PubMed ID: 31563468
[TBL] [Abstract][Full Text] [Related]
9. Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1.
Lertdumrongluk P; Streja E; Rhee CM; Moradi H; Chang Y; Reddy U; Tantisattamo E; Kalantar-Zadeh K; Kopp JB
Cardiorenal Med; 2019; 9(4):212-221. PubMed ID: 30995638
[TBL] [Abstract][Full Text] [Related]
10. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
11. Clinical Genetic Testing for APOL1: Are we There Yet?
Young BA; Fullerton SM; Wilson JG; Cavanaugh K; Blacksher E; Spigner C; Himmelfarb J; Burke W
Semin Nephrol; 2017 Nov; 37(6):552-557. PubMed ID: 29110763
[TBL] [Abstract][Full Text] [Related]
12. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
Tzur S; Rosset S; Skorecki K; Wasser WG
Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
[TBL] [Abstract][Full Text] [Related]
13. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
14. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
[TBL] [Abstract][Full Text] [Related]
15. APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.
Ng DK; Robertson CC; Woroniecki RP; Limou S; Gillies CE; Reidy KJ; Winkler CA; Hingorani S; Gibson KL; Hjorten R; Sethna CB; Kopp JB; Moxey-Mims M; Furth SL; Warady BA; Kretzler M; Sedor JR; Kaskel FJ; Sampson MG
Nephrol Dial Transplant; 2017 Jun; 32(6):983-990. PubMed ID: 27190333
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.
Larsen CP; Beggs ML; Saeed M; Walker PD
J Am Soc Nephrol; 2013 Apr; 24(5):722-5. PubMed ID: 23520206
[TBL] [Abstract][Full Text] [Related]
17. Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.
Nadkarni GN; Chauhan K; Verghese DA; Parikh CR; Do R; Horowitz CR; Bottinger EP; Coca SG
Kidney Int; 2018 Jun; 93(6):1409-1416. PubMed ID: 29685497
[TBL] [Abstract][Full Text] [Related]
18. APOL1 Gene Variants and Risk for Cardiovascular Disease.
Duran CE; Estacio M; Espinosa D; Manzi E; Posada JG; Mesa L; Schweineberg J
Kidney Blood Press Res; 2023; 48(1):785-790. PubMed ID: 37778341
[TBL] [Abstract][Full Text] [Related]
19. Association of
Bick AG; Akwo E; Robinson-Cohen C; Lee K; Lynch J; Assimes TL; DuVall S; Edwards T; Fang H; Freiberg SM; Giri A; Huffman JE; Huang J; Hull L; Kember RL; Klarin D; Lee JS; Levin M; Miller DR; Natarajan P; Saleheen D; Shao Q; Sun YV; Tang H; Wilson O; Chang KM; Cho K; Concato J; Gaziano JM; Kathiresan S; O'Donnell CJ; Rader DJ; Tsao PS; Wilson PW; Hung AM; Damrauer SM;
Circulation; 2019 Sep; 140(12):1031-1040. PubMed ID: 31337231
[TBL] [Abstract][Full Text] [Related]
20. Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders.
Adamson WE; Noyes H; Johnson P; Cooper A; Monckton DG; Ogunsola J; Beckett-Hill G; Sullivan M; Mark P; Parekh RS; MacLeod A
EBioMedicine; 2024 Mar; 101():105000. PubMed ID: 38360481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
